(Q33266265)

24 July 2017

title

Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma (English)

1 reference

head and neck squamous cell carcinoma

24 July 2017

main subject

0 references

1 reference

Luciënne Speleman

1

1 reference

24 July 2017

Jeroen D F Kerrebijn

2

1 reference

24 July 2017

Maxime P Look

3

1 reference

24 July 2017

Cees A Meeuwis

4

1 reference

24 July 2017

John A Foekens

5

1 reference

24 July 2017

Els M J J Berns

6

1 reference

24 July 2017

publication date

1 April 2007

1 reference

24 July 2017

1 reference

24 July 2017

volume

29

1 reference

24 July 2017

issue

4

1 reference

24 July 2017

page(s)

341-350

1 reference

Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck.

24 July 2017

cites work

1 reference

Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx

21 January 2018

1 reference

Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value

21 January 2018

1 reference

The Myofibroblast Is the Predominant Plasminogen Activator Inhibitor-1-Expressing Cell Type in Human Breast Carcinomas

21 January 2018

1 reference

Potential molecular prognostic markers in head and neck squamous cell carcinomas

21 January 2018

1 reference

7 January 2021

1 reference

7 January 2021

Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives

1 reference

7 January 2021

Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma

1 reference

7 January 2021

Predictive value of cathepsin-D for cervical lymph node metastasis in head and neck squamous cell carcinoma

1 reference

7 January 2021

Perineural invasion in squamous cell carcinoma of the head and neck

1 reference

7 January 2021

The Hallmarks of Cancer

1 reference

7 January 2021

Novel methods for the determination of the angiogenic activity of human tumors

1 reference

7 January 2021

Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression

1 reference

7 January 2021

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis

1 reference

7 January 2021

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

1 reference

7 January 2021

Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute

1 reference

7 January 2021

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

1 reference

7 January 2021

Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors

1 reference

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

7 January 2021

Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck

1 reference

7 January 2021

Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients

1 reference

7 January 2021

Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis

1 reference

7 January 2021

Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs

1 reference

7 January 2021

In vitro urokinase type plasminogen activator levels and total plasminogen activator activity in squamous cell carcinomas of the head and neck

1 reference

7 January 2021

Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity

1 reference

7 January 2021

Novel markers for poor prognosis in head and neck cancer.

1 reference

7 January 2021

[Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma]

1 reference

7 January 2021

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

7 January 2021

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer

1 reference

7 January 2021

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

7 January 2021

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

1 reference

7 January 2021

Regulation of cell adhesion by PAI-1.

1 reference

7 January 2021

Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth

1 reference

7 January 2021

Leading-Edge Myofibroblasts in Human Colon Cancer Express Plasminogen Activator Inhibitor-1

1 reference

7 January 2021

Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissue

1 reference

7 January 2021

Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshop

1 reference

7 January 2021

Surgical treatment of early-stage carcinoma of the oral tongue--wound adjuvant treatment be beneficial?

1 reference

7 January 2021

Prognostic implications of perineural spread in squamous carcinomas of the head and neck

1 reference

7 January 2021

Microvascular invasion and survival in cancer of the oral cavity and oropharynx

1 reference

7 January 2021

Treatment of stage I and II oral tongue cancer

1 reference

7 January 2021

Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosis

1 reference

7 January 2021

1 reference

7 January 2021

The many roles of c-Myc in apoptosis

1 reference

7 January 2021

Oncogene amplification in squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Analysis of gene amplification in head-and-neck squamous-cell carcinoma

1 reference

7 January 2021

c-myc oncogene copy number in squamous carcinoma of the head and neck.

1 reference

7 January 2021

MYC amplification in squamous cell carcinomas of the head and neck

1 reference

7 January 2021

CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas

1 reference

7 January 2021

Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas

1 reference

7 January 2021

Immunohistochemical detection of c-myc protein in head and neck tumors

1 reference

7 January 2021

The Detection of thec-mycandrasOncogenes in Nasopharyngeal Carcinoma by Immunohistochemistry

1 reference

7 January 2021

Significance of c-Myc and Bcl-2 protein expression in nasopharyngeal carcinoma

1 reference

7 January 2021

Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20527

1 reference

24 July 2017

1 reference